Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term intermittent maintenance tacrolimus ointment in children with moderate to severe atopic dermatitis
ChiCTR-TRC-12002479Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- May 2012
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in atopic dermatitis (AD) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Time to first recurrence. Started May 2012; status: completed.
02
Drugs
tacrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR-TRC-12002479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002479.